CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 12,771 shares (grant or award)
- 4 Grant or award Director acquired 11,684 shares (grant or award)
- 4 Open-market sale CEO and Chairman of the Board sold 10,000 shares at $1.62 ($16,200)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CEO and Chairman of the Board acquired 70,155 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 67,187 shares (grant or award)
- 4 Grant or award Director acquired 79,687 shares (grant or award)
- 4 Grant or award Director acquired 73,437 shares (grant or award)
- 4 Grant or award Director acquired 23,783 shares (grant or award)
- 4 Grant or award Director acquired 28,207 shares (grant or award)
- 4 Grant or award Director acquired 25,995 shares (grant or award)
Page 2 of 5 · 82 filings